Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

The combination treatment showed a higher response rate but no significant survival benefits.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

CTP-543 is generally safe for treating alopecia areata.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

New compounds show promise as nonsteroidal treatments for hair loss.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Ketoconazole is effective for treating various fungal infections and has new uses in dermatology, but oral use can have serious side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.